CA CLASS ACTION SEEKS $7.5 BILLION FROM KNOLL FOR SUPPRESSING STUDY Scheibel v. Knoll Pharmaceutical Co. | Secondary Sources | Westlaw

CA CLASS ACTION SEEKS $7.5 BILLION FROM KNOLL FOR SUPPRESSING STUDY Scheibel v. Knoll Pharmaceutical Co. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, CA CLASS ACTION SEEKS $7.5 BILLION FROM KNOLL FOR SUPPRESSING STUDY Scheibel v. Knoll Pharmaceutical Co., Secondary Sources
1997-JUN Andrews Antitrust Litig. Rep. 12
Andrews Antitrust Litigation Reporter
June, 1997
Monopoly/RICO
Copyright (c) 1997 Andrews Publications

CA CLASS ACTION SEEKS $7.5 BILLION FROM KNOLL FOR SUPPRESSING STUDY

Scheibel v. Knoll Pharmaceutical Co.

Knoll Pharmaceutical Co. allegedly suppressed a scientific study it had commissioned because the results showed that its synthetic thyroid hormone Synthroid is no more effective in treating hypothyroidism than generic forms of the drug costing about...
End of Document© 2023 Thomson Reuters. No claim to original U.S. Government Works.